Listen to this article:

New Delhi: While US president Donald Trump has announced 26% reciprocal tariffs on India, the country’s pharmaceutical industry has heaved a sigh of relief as the sector has been exempted from the new levies. 

According to a fact sheet released by the White House following Trump’s speech on April 2, pharmaceutical companies worldwide will not be facing reciprocal taxes. 

Currently, the US ranks at the top of the list of the countries to which Indian pharma companies export their products.

According to Pharmaceuticals Export Council of India (Pharmexcil), Indian pharma companies exported products worth US $ 8728.60 million in the 2024-25 financial year. This was 15.66% higher than the previous year. Pharmexcil is a body established under Union ministry of commerce and industry. 

Second is the UK, to which Indian pharma companies supplied products worth US $ 784.32 million in FY24, according to Pharmexil. 

These........

© The Wire